BOSTON (WBZ NewsRadio) — Production and distribution of Excedrin Extra Strength and Excedrin Migraine products is being halted as a precautionary measure.
Pharmaceutical company GlaxoSmithKline said it has temporarily discontinued the two types of painkillers in both caplet and geltab form.
"Through routine quality control and assurance measures, we discovered inconsistencies in how we transfer and weigh ingredients," the company's statement said.
GlaxoSmithKline said it does not believe the discontinued products pose any safety risk to consumers, but that it voluntarily implemented the measure as a precaution.
For those concerned about going without their go-to pain medication, the company has some advice. While production is expected to resume shortly, Excedrin Tension Headache and Excedrin PM medications are still available nationwide. GlaxoSmithKline says those could be effective alternatives for anyone who chooses to steer clear of the discontinued Migraine and Extra Strength products.
"We are working hard to resolve the issue as quickly as possible, but at this point in time cannot confirm a definite date as to when supply will resume," the company said. "Other Excedrin products are available along with other pain-relieving drugs, but dosages may differ. Consumers should consult their pharmacist for the most suitable alternative product."